10.28 (-%)
As of Dec 10, 2024
Source:
Y-Mabs Therapeutics, Inc. is a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based therapeutic products for the treatment of cancer.
Country | United States |
Headquarters | new york, new york |
Phone Number | (646)-885-8505 |
Industry | manufacturing |
CEO | Michael Rossi |
Website | www.ymabs.com |